![Scott Nogi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Nogi
Geschäftsführer bei
DIANTHUS THERAPEUTICS, INC.
Profil
Scott Nogi is currently Head-Business Operations at Dianthus Therapeutics, Inc. since 2023.
Formerly, Mr. Nogi was Executive Director at Kolot Chayeinu from 2014 to 2017.
Mr. Nogi served as Vice President at SCO Capital Partners LLC, SCO Financial Group LLC, and SCO Capital Management LLC, with the latter role specified as Vice President-Operation.
From 2018 to 2022, Mr. Nogi was Vice President & Head-Business Operations at Abeona Therapeutics, Inc. Education includes undergraduate studies at New York University and an MBA from The Leonard N Stern School of Business.
Aktive Positionen von Scott Nogi
| Unternehmen | Position | Beginn |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Geschäftsführer | 11.09.2023 |
Ehemalige bekannte Positionen von Scott Nogi
| Unternehmen | Position | Ende |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Corporate Officer/Principal | 01.07.2022 |
Kolot Chayeinu | Direktor/Vorstandsmitglied | 01.07.2017 |
SCO Capital Management LLC | Geschäftsführer | - |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Corporate Officer/Principal | - |
SCO Capital Partners LLC
 SCO Capital Partners LLC Investment ManagersFinance SCO invests in value-oriented, micro-cap life sciences companies. They also structure and execute private placement financings. SCO is typically the lead investor in PIPE transactions and then acts as placement agent to complete the financing round. They may call on co-investors to raise additional funds in both initial and future financings. SCO also serves as strategic advisors on mergers and acquisitions and corporate partnerships. | Private-Equity-Analyst | 04.11.2010 |
Ausbildung von Scott Nogi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
SCO Capital Partners LLC
SCO Capital Partners LLC Investment ManagersFinance SCO invests in value-oriented, micro-cap life sciences companies. They also structure and execute private placement financings. SCO is typically the lead investor in PIPE transactions and then acts as placement agent to complete the financing round. They may call on co-investors to raise additional funds in both initial and future financings. SCO also serves as strategic advisors on mergers and acquisitions and corporate partnerships. | Finance |
SCO Financial Group LLC
SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Finance |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SCO Capital Management LLC | |
Kolot Chayeinu | |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
